PARSIPPANY, N.J.--(BUSINESS WIRE)--YARAL Pharma Inc. (YARAL Pharma), the U.S. generics subsidiary of IBSA (Institut Biochimique SA), a multinational pharmaceutical company headquartered in Lugano, ...
A widely prescribed thyroid medication called levothyroxine may cause bone loss and increase the risk of the bone disease osteoporosis, according to new research—but this does not mean Americans ...
Levothyroxine, a common medication for hypothyroidism sold as Synthroid, is linked to bone loss in older adults, a new study ...
Taiwan’s Food and Drug Administration has initiated a recall of more than 1.12 million tablets of a thyroid medication ...
Here are six new drug shortages and discontinuations, according to drug supply databases from the FDA. Levothyroxine sodium tablet: EMD Serono has discontinued all presentations of Euthyrox ...
W A S H I N G T O N, July 12 -- The government has advised makers of somewidely used thyroid drugs that they will have to begin cutting backdistribution of any that haven't won agency approval by Aug.
Widespread reports of side effects linked to changes in the formulation of the hypothyroidism drug levothyroxine (Levothyrox, Merck) in France have forced the company to put its previous formulation — ...
Among women with a history of miscarriage or subfertility, the prevalence of subclinical hypothyroidism is about 20% when using a TSH cutoff of 2.5 mIU/L, according to a prospective observational ...
Once-weekly SC levothyroxine (XP-8121) participants normalized TSH/T4 levels using 45% less drug than would be needed for their daily oral dose on a weekly basis Data established an average ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results